MedPath

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Interventions
Other: Varying the nicotine content of cigarettes
Other: E-Cigarettes
Registration Number
NCT04092387
Lead Sponsor
University of Vermont
Brief Summary

Despite marked reductions in cigarette smoking in the general population, smoking among economically disadvantaged women has increased. Smoking among women of reproductive age is a particular concern because in addition to the usual health risks, there are additional risks should they become pregnant. A national nicotine reduction policy for cigarettes has considerable potential to reduce tobacco use, dependence, and improve health in this population. Controlled trials in general population samples have demonstrated that reducing the nicotine content in cigarettes can reduce cigarettes per day (CPD), dependence severity, and tobacco toxicant exposure.

The goal of the proposed trial is to experimentally examine whether increasing the availability and appeal of an alternative, non-combusted source of nicotine (e-cigarettes) enhances the effect of altering the nicotine in cigarettes in non-pregnant female cigarette smokers of childbearing age. Additionally, investigators will test whether allowing participants to personalize the flavor of the e-liquid alters any moderating effects their availability may have on tobacco cigarette smoking.

Daily smokers who are female, aged 21-44 years, and have a maximum educational attainment of graduating high school, will be recruited at Johns Hopkins University and the University of Vermont.

Investigators will study two research cigarettes referred to here as Research Cigarettes 1 (RC1) and Research Cigarettes 2 (RC2). One will be a normal nicotine content cigarette and the other a reduced nicotine content cigarette. Investigators will study two e-cigarette conditions referred to here as E-Cigarette Condition 1 (EC1) and E-Cigarette Condition 2 (EC2). Both e-cigarette conditions will involve the same commercially available devices and same nicotine-containing e-liquid, but in one condition that e-liquid will be available only in tobacco flavor while in the other the e-liquid will be available in multiple flavors from which participants can choose three based on personal preference. Participants will be assigned to one of the following four conditions: (1) RC1 only; (2) RC2 only; (3) RC2 + EC1; (4) RC2 + EC2.

Participants will be asked to use only their assigned study products for 16 weeks. Outcome measures include total CPD, craving, withdrawal, psychiatric symptoms, breath carbon monoxide (CO), other biomarkers of tobacco toxicant exposure, and cigarette demand assessed by behavioral economic purchase tasks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Female
  • 21 to 44 years old
Read More
Exclusion Criteria
  • Male
  • Under 21 years old
  • Over 44 years old
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RC 2 + EC 1E-CigarettesResearch Cigarettes #2 plus E-cigarettes #1
RC 2 onlyVarying the nicotine content of cigarettesResearch Cigarettes #2
RC 2 + EC 2Varying the nicotine content of cigarettesResearch Cigarettes #2 plus E-cigarettes #2
RC 2 + EC 2E-CigarettesResearch Cigarettes #2 plus E-cigarettes #2
RC 1 onlyVarying the nicotine content of cigarettesResearch cigarettes #1
RC 2 + EC 1Varying the nicotine content of cigarettesResearch Cigarettes #2 plus E-cigarettes #1
Primary Outcome Measures
NameTimeMethod
Number of Cigarettes Smoked Per Day16 weeks

Cigarettes per day will be assessed for use of cigarettes with different nicotine content.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of Vermont

🇺🇸

Burlington, Vermont, United States

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath